These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7377594)

  • 1. Time-dependent increase in sensitivity to d-tubocurarine during enflurane anesthesia in man.
    Stanski DR; Ham J; Miller RD; Sheiner LB
    Anesthesiology; 1980 Jun; 52(6):483-7. PubMed ID: 7377594
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuromuscular effects of enflurane, alone and combined with d-Tubocurarine, pancuronium, and succinylcholine, in man.
    Fogdall RP; Miller RD
    Anesthesiology; 1975 Feb; 42(2):173-8. PubMed ID: 1115366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of d-tubocurarine during nitrous oxide-narcotic and halothane anesthesia in man.
    Stanski DR; Ham J; Miller RD; Sheiner LB
    Anesthesiology; 1979 Sep; 51(3):235-41. PubMed ID: 475025
    [No Abstract]   [Full Text] [Related]  

  • 4. Duration of halothane anesthesia and neuromuscular blockade with d-tubocurarine.
    Miller RD; Crique M; Eger EI
    Anesthesiology; 1976 Mar; 44(3):206-10. PubMed ID: 1267887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potentiation of the neuromuscular blocking activity of hexafluorenium and d-tubocurarine by volatile anaesthetics.
    Vermeer GA; Hess SW
    Anaesthesist; 1974 Feb; 23(2):72-8. PubMed ID: 4458482
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential increase in potency of neuromuscular blocking agents by enflurane and halothane.
    Schuh FT
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):383-6. PubMed ID: 6629542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular effects of atracurium during halothane-nitrous oxide and enflurane-nitrous oxide anesthesia in humans.
    Rupp SM; McChristian JW; Miller RD
    Anesthesiology; 1985 Jul; 63(1):16-9. PubMed ID: 3160265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of the elimination and neuromuscular blocking effect of d-tubocurarine in man.
    Gibaldi M; Levy G; Hayton W
    Anesthesiology; 1972 Mar; 36(3):213-8. PubMed ID: 5011414
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of d-tubocurarine pharmacokinetics in humans and dogs.
    Ramzan IM; Shanks CA; Triggs EJ
    Anaesth Intensive Care; 1978 Feb; 6(1):30-5. PubMed ID: 665974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in dose requirement of d-tubocurarine by volatile anesthetics.
    Waud BE
    Anesthesiology; 1979 Oct; 51(4):298-302. PubMed ID: 39476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of d-tubocurarine in man with and without renal failure.
    Miller RD; Matteo RS; Benet LZ; Sohn YJ
    J Pharmacol Exp Ther; 1977 Jul; 202(1):1-7. PubMed ID: 195035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neostigmine antagonism of vecuronium paralysis during fentanyl, halothane, isoflurane, and enflurane anesthesia.
    Dernovoi B; Agoston S; Barvais L; Baurain M; Lefebvre R; d'Hollander A
    Anesthesiology; 1987 May; 66(5):698-701. PubMed ID: 2883916
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of diethyl ether, enflurane, and isoflurane at the neuromuscular junction.
    Waud BE; Waud DR
    Anesthesiology; 1975 Mar; 42(3):275-80. PubMed ID: 124148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of halothane on tubocurarine and suxamethonium block in man.
    Baraka A
    Br J Anaesth; 1968 Aug; 40(8):602-6. PubMed ID: 5243759
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular effects of metocurine during enflurance anesthesia in man.
    Stanley TH
    Anesth Analg; 1978; 57(5):540-3. PubMed ID: 568421
    [No Abstract]   [Full Text] [Related]  

  • 16. Questions regarding a time-dependent increase in sensitivity to d-tubocurarine during enflurane anesthesia.
    Feingold A
    Anesthesiology; 1981 Mar; 54(3):260-2. PubMed ID: 7469114
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of pipecuronium bromide during halothane or enflurane anesthesia--a comparison with pancuronium regarding the optimal dose and the effect of volatile anesthetics on neuromuscular blockade].
    Amaki Y; Yamamura H
    Masui; 1993 Jun; 42(6):876-82. PubMed ID: 8391589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vecuronium-induced neuromuscular blockade during enflurane, isoflurane, and halothane anesthesia in humans.
    Rupp SM; Miller RD; Gencarelli PJ
    Anesthesiology; 1984 Feb; 60(2):102-5. PubMed ID: 6141748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreasing enflurane concentrations and d-tubocurarine neuromuscular blockade.
    Gencarelli PJ; Miller RD; Eger EI; Newfield P
    Anesthesiology; 1982 Mar; 56(3):192-4. PubMed ID: 7059028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular and electromyographic effects of halothane and its interaction with d-tubocurarine in man.
    Katz RL; Gissen AJ
    Anesthesiology; 1967; 28(3):564-7. PubMed ID: 4225766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.